RT Journal Article
SR Electronic
T1 Papillary thyroid microcarcinoma with and without nodal metastasis
JF Saudi Medical Journal
JO Saudi Med J
FD Prince Sultan Military Medical City
SP 267
OP 272
DO 10.15537/smj.2024.45.3.20230638
VO 45
IS 3
A1 Alqaryan, Saleh
A1 Almousa, Hisham
A1 Almutairi, Raed
A1 Altuwaijri, Ahmed
A1 Doubi, Aseel
A1 Alqahtani, Zuhour
A1 Almayouf, Mohammad
A1 Albarrak, Majed
A1 Alessa, Mohammed
A1 Aldhahri, Saleh
A1 Alqahtani, Khalid
YR 2024
UL http://smj.org.sa/content/45/3/267.abstract
AB Objectives: To assess the demographics and clinical factors of papillary thyroid microcarcinoma (PTMC) patients in Saudi Arabia and compared and analyzed the differences between the patients with and without lymph node metastasis (LNM). Papillary thyroid microcarcinoma (PTMC) is a common thyroid cancer and is not usually detectable clinically but found incidentally after pathologic evaluation of thyroid tissue following surgery for benign thyroid disorders. However, these tumors have a significant risk of LNM.Methods: All PTMC patients who underwent surgery at King Abdulaziz University Hospital, King Fahad Medical City, and King Abdulaziz Medical City from 2012 to 2022 were included. The incidence rate of LNM was 9.17%. The patients’ average age was 44.05. Most of the patients were female.Results: Prevalence of LNM among PTMC patients is 9.17% (n=31). The PTMC patients showed the following significant risk factors for LNM: higher Bethesda class, type of pathology, extrathyroidal extension, extracapsular extension, lymphovascular invasion, and residual tumors in patients who had received radioactive iodine. Presence of thyroiditis, multifocality, goitrous thyroid, neural invasion, and tumor size were unrelated to the LNM in the PTMC patients.Conclusion: Higher Bethesda class, pathology type, extrathyroidal extension, extracapsular extension, lymphovascular invasion, and RAI-treated residual tumors were strongly linked to LNM.